XML 83 R18.htm IDEA: XBRL DOCUMENT
v3.19.3

Stockholders' Equity | 12 Months Ended
--- | ---
Sep. 30, 2019
Equity [Abstract] |
Shareholders' Equity and Share-based Payments [Text Block] | 12. STOCKHOLDERS’ EQUITY Equity Incentive Plan The Company’s 2006 Equity Incentive Plan, as amended and restated (the “Equity Incentive Plan”), provides for grants of stock options as well as grants of stock, including restricted stock. Approximately 3.0 million shares of common stock are authorized for issuance under the Equity Incentive Plan, of which approximately 824,676 shares were available for issuance at September 30, 2019. Stock Repurchase Program In 2015, our Board of Directors authorized a stock repurchase program for the purchase from time to time of up to 1.5 million shares of the Company’s common stock, and on May 2, 2019, authorized the repurchase from time to time of up to an additional 1.0 million shares of our common stock under the stock repurchase program. Share purchases are made for cash in open market transactions at prevailing market prices or in privately negotiated transactions or otherwise. The timing and amount of purchases under the program are determined based upon prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. All or part of the repurchases may be implemented under a Rule 10b5-1 trading plan, which allows repurchases under pre-set terms at times when the Company might otherwise be prevented from purchasing under insider trading laws or because of self-imposed blackout periods. The program does not require the Company to purchase any specific number of shares and may be modified, suspended or reinstated at any time at the Company’s discretion and without notice. We repurchased 467,819 shares of our common stock during the year ended September 30, 2019, in open market transactions at an average price of $17.34 per share. We repurchased 100,627 shares of our common stock during the year ended September 30, 2018, in open market transactions at an average price of $15.41 per share. Treasury Stock During the year ended September 30, 2019, we issued 216,679 shares of common stock from treasury and repurchased 97,003 shares of common stock from our employees to satisfy statutory tax withholding requirements upon the vesting of certain performance phantom stock units under the Equity Incentive Plan. We also repurchased 467,819 shares of common stock on the open market pursuant to our stock repurchase program. During the year ended September 30, 2019, we issued 1,923 unrestricted shares of common stock from treasury to members of our Board of Directors as part of their overall compensation and 22,500 unrestricted shares to satisfy the exercise of outstanding options. We also issued 283,195 shares out of treasury for restricted shares granted upon the appointment of the Company’s Chief Executive Officer in March 2019 (as described below). During the year ended September 30, 2018, we repurchased 32,832 shares of common stock from our employees to satisfy minimum tax withholding requirements upon the vesting of restricted stock under the Equity Incentive Plan and repurchased 100,627 shares of common stock on the open market pursuant to our stock repurchase program. During the year ended September 30, 2018, we issued 520 unrestricted shares of common stock from treasury to members of our Board of Directors as part of their overall compensation and 1,500 unrestricted shares to satisfy the exercise of outstanding options. Restricted Stock During the years ended September 30, 2019, 2018, and 2017, we recognized $776, $256, and $538, respectively, in compensation expense related to our restricted stock awards. At September 30, 2019, the unamortized compensation cost related to outstanding unvested restricted stock was $3,024. A summary of restricted stock awards for the years ended September 30, 2019, 2018, and 2017 is provided in the table below:
| Year Ended September 30,
| 2019 |  | 2018 |  | 2017
Unvested at beginning of year | — |  |  | 140,668 |  |  | 174,334 |
Granted | 283,195 |  |  | — |  |  | — |
Vested | — |  |  | (140,668 | ) |  | (31,409 | )
Forfeited | — |  |  | — |  |  | (2,257 | )
Unvested at end of year | 283,195 |  |  | — |  |  | 140,668 |
The fair value of shares vesting during the years ended September 30, 2019, 2018, and 2017 was $0, $2,201 and $460, respectively. Fair value was calculated as the number of shares vested times the market price of shares on the date of vesting. At September 30, 2019, we had unvested restricted stock of $3,800. Vesting of this restricted stock is as follows:
1. | Time-Based Award: 80,000 restricted shares vest over a four-year period ending March 4, 2023, based on continued employment with the Company, with 20,000 shares vesting each year.
2. | Long-term Incentive Plan Award: Subject to a service requirement, 23,195 restricted shares vest contingent upon the Company achieving specified performance targets for the three-year period ending September 30, 2021.
3. | Stock Price-Based Awards: Subject to a service requirement, 180,000 restricted shares vest in four tranches when the closing price per share of the Company's common stock equals or exceeds the price specified below for such tranche for any 20 trading days out of 25 consecutive trading days (the "Vesting Stock Price") at any time during the five years ending March 4, 2024.
| a. | Tranche 1: 60,000 shares with a Vesting Stock Price of $35 per share;
| b. | Tranche 2: 40,000 shares with a Vesting Stock Price of $40 per share;
| c. | Tranche 3: 40,000 shares with a Vesting Stock Price of $45 per share;
| d. | Tranche 4: 40,000 shares with a Vesting Stock Price of $50 per share;
All the restricted shares granted under the Equity Incentive Plan (vested or unvested) participate in dividends issued to common shareholders, if any. Director Phantom Stock Units Director phantom stock units (“Director PSUs”) are primarily granted to the members of the Board of Directors as part of their overall compensation. These Director PSUs are paid via unrestricted stock grants to each director upon their departure from the Board of Directors. We record compensation expense for the full value of the grant on the date of grant. For the years ended September 30, 2019, 2018, and 2017, we recognized $300, $189, and $167, respectively, in compensation expense related to these grants. At September 30, 2019, the Company had an aggregate of 210,386 Director PSUs outstanding. Employee Phantom Stock Units An employee phantom stock unit (an “Employee PSU”) is a contractual right to receive one share of the Company’s common stock. Depending on the terms of each grant, Employee PSUs may vest upon the achievement of certain specified performance objectives and continued performance of services, or may vest based on continued performance of services through the vesting date. On February 6, 2019, the Company granted Employee PSUs, which, subject to the achievement of certain performance metrics, could result in the issuance of 264,815 shares of common stock. Of these Employee PSUs, 97,985 Employee PSUs were forfeited during the year ended September 30, 2019, and 3,991 Employee PSUs vested in conjunction with the departure of Company employees. As of September 30, 2019, a maximum of 162,840 shares of common stock may be issued under outstanding Employee PSUs. During the year ended September 30, 2019, we recognized compensation expense of $1,151 related to these grants. The vesting of these awards is subject to either the achievement of specified levels of cumulative net income before taxes or specified stock price levels and continued performance of services through mid-December 2021, or based on continued performance through the vesting date alone. At September 30, 2019, redemption of a portion of the awards is deemed probable. During the year ended September 30, 2018, we recognized a benefit to compensation expense of $581 related to Employee PSU grants. This benefit was the result of a reduction in the estimated number of units deemed probable of vesting, based on the projected achievement of specified performance objectives. Stock Options We did not issue stock options during the years ended September 30, 2019, 2018 and 2017. The following table summarizes activity relating to options granted in the years ended September 30, 2013 and 2015.
| Shares |  | Weighted Average Exercise Price
Outstanding, September 30, 2016 | 79,500 |  |  | $ | 6.43 |
Options granted | — |  |  | — |
Exercised | 33,750 |  |  | 6.46 |
Forfeited and canceled | — |  |  | — |
Outstanding, September 30, 2017 | 45,750 |  |  | $ | 6.42 |
Options granted | — |  |  | — |
Exercised | 1,500 |  |  | 7.21 |
Forfeited and canceled | — |  |  | — |
Outstanding, September 30, 2018 | 44,250 |  |  | $ | 6.39 |
Options granted | — |  |  | — |
Exercised | 22,500 |  |  | 6.43 |
Forfeited and canceled | — |  |  | — |
Outstanding, September 30, 2019 | 21,750 |  |  | $ | 6.35 |
The following table summarizes options outstanding and exercisable at September 30, 2019:
Outstanding and Exercisable as of September 30, 2019 |  | Remaining Contractual Life in Years |  | Weighted-Average Exercise Price
13,000 |  |  | 3.58 |  | $5.76
1,000 |  |  | 5.29 |  | $7.27
7,750 |  |  | 5.34 |  | $7.21
21,750 |  |  |  |  | $6.35
Our 2013 and 2015 options cliff vested at the end of a two year period ending at the anniversary date of the grant. All options expire ten years from the grant date if they are not exercised. Upon exercise of stock options, it is our policy to first issue shares from treasury, then issue new shares. Unexercised stock options expire May 2023, January 2025 and February 2025. During the years ended September 30, 2019, 2018, and 2017, we recognized zero, zero and $23, respectively, in compensation expense related to our stock option awards. The intrinsic value of stock options outstanding and exercisable was $254 and $292 at September 30, 2019, and 2018, respectively. The intrinsic value is calculated as the difference between the fair value as of the end of the period and the exercise price of the stock options.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration